Titin truncating variants, cardiovascular risk factors and the risk of atrial fibrillation and heart failure

IF 9.4 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Naman S. Shetty, Mokshad Gaonkar, Akhil Pampana, Nirav Patel, Peng Li, Garima Arora, Pankaj Arora
{"title":"Titin truncating variants, cardiovascular risk factors and the risk of atrial fibrillation and heart failure","authors":"Naman S. Shetty, Mokshad Gaonkar, Akhil Pampana, Nirav Patel, Peng Li, Garima Arora, Pankaj Arora","doi":"10.1038/s44161-024-00511-2","DOIUrl":null,"url":null,"abstract":"High-proportion spliced-in (hiPSI) titin truncating variant (TTNtv) carriers have a higher risk of atrial fibrillation and heart failure1. However, the role of cardiovascular risk factors in modifying the risk of atrial fibrillation and heart failure attributed to hiPSI TTNtv carriers is unknown. Here, we investigate the role of cardiovascular risk, quantified using the pooled cohort equations (PCEs), in influencing the hazard of outcomes attributed to hiPSI TTNtvs among UK Biobank participants without baseline cardiovascular disease. The cohort was stratified based on hiPSI TTNtv carrier status and cardiovascular risk (low: <5%, intermediate: 5.0–7.5% and high: >7.5%). The primary outcome was a composite of atrial fibrillation, heart failure or death. TTNtv noncarriers with low cardiovascular risk were used as the reference group for all analyses. Among 179,752 participants (median age: 56 (49, 62) years; 57.5% female), the risk of the primary outcome was lower in hiPSI TTNtv carriers with low cardiovascular risk (adjusted hazard ratio: 2.23 (95% confidence interval: 1.62–3.07)) than those with high cardiovascular risk (adjusted hazard ratio: 8.21 (95% confidence interval: 6.63–10.18)). A favorable cardiovascular risk factor profile may partially offset the risk of clinical outcomes among hiPSI TTNtv carriers. Shetty et al. report that a favorable cardiovascular risk factor profile may partially offset the risk of heart failure and atrial fibrillation among carriers of high-proportion spliced-in titin truncating variants.","PeriodicalId":74245,"journal":{"name":"Nature cardiovascular research","volume":"3 8","pages":"899-906"},"PeriodicalIF":9.4000,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature cardiovascular research","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44161-024-00511-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

High-proportion spliced-in (hiPSI) titin truncating variant (TTNtv) carriers have a higher risk of atrial fibrillation and heart failure1. However, the role of cardiovascular risk factors in modifying the risk of atrial fibrillation and heart failure attributed to hiPSI TTNtv carriers is unknown. Here, we investigate the role of cardiovascular risk, quantified using the pooled cohort equations (PCEs), in influencing the hazard of outcomes attributed to hiPSI TTNtvs among UK Biobank participants without baseline cardiovascular disease. The cohort was stratified based on hiPSI TTNtv carrier status and cardiovascular risk (low: <5%, intermediate: 5.0–7.5% and high: >7.5%). The primary outcome was a composite of atrial fibrillation, heart failure or death. TTNtv noncarriers with low cardiovascular risk were used as the reference group for all analyses. Among 179,752 participants (median age: 56 (49, 62) years; 57.5% female), the risk of the primary outcome was lower in hiPSI TTNtv carriers with low cardiovascular risk (adjusted hazard ratio: 2.23 (95% confidence interval: 1.62–3.07)) than those with high cardiovascular risk (adjusted hazard ratio: 8.21 (95% confidence interval: 6.63–10.18)). A favorable cardiovascular risk factor profile may partially offset the risk of clinical outcomes among hiPSI TTNtv carriers. Shetty et al. report that a favorable cardiovascular risk factor profile may partially offset the risk of heart failure and atrial fibrillation among carriers of high-proportion spliced-in titin truncating variants.

Abstract Image

钛蛋白截短变体、心血管风险因素以及心房颤动和心力衰竭的风险
高比例剪接(hiPSI)滴定蛋白截短变异体(TTNtv)携带者罹患心房颤动和心力衰竭的风险较高1。然而,心血管风险因素在改变hiPSI TTNtv携带者心房颤动和心力衰竭风险中的作用尚不清楚。在此,我们利用集合队列方程(PCEs)对心血管风险进行量化,研究心血管风险在影响无心血管疾病基线的英国生物库参与者中的 hiPSI TTNtvs 结局风险中的作用。根据 hiPSI TTNtv 携带者状态和心血管风险(低:5%;中:5.0-7.5%;高:7.5%)对队列进行了分层。主要结果是心房颤动、心力衰竭或死亡的综合结果。所有分析均以心血管风险较低的非 TTNtv 携带者为参照组。在 179,752 名参与者(中位年龄:56(49,62)岁;57.5% 为女性)中,心血管风险低的 hiPSI TTNtv 携带者发生主要结局的风险(调整后危险比:2.23(95% 置信区间:1.62-3.07))低于心血管风险高的人(调整后危险比:8.21(95% 置信区间:6.63-10.18))。有利的心血管风险因素可能会部分抵消 hiPSI TTNtv 携带者的临床结果风险。Shetty 等人报告说,有利的心血管风险因素可能会部分抵消高比例剪接入滴定截短变异体携带者患心力衰竭和心房颤动的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信